Article
GBP2 acts as a member of the interferon signaling pathway in lupus nephritis
2022-07-13
Abstract excerpt
Lupus nephritis (LN) is a common and serious clinical manifestation of systemic lupus erythematosus (SLE). However, the pathogenesis of LN is not fully understood. The currently available treatments do not cure the disease and appear to have a variety of side effects in the long term. The purpose of this study was to search for key molecules involved in the immune response during the development of LN through bioi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 797415fd-3eab-5699-aab7-0cda2119dcd0
- DOI
- 10.21203/rs.3.rs-1825785/v1
